The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Mimicry of CD40 Signals by Epstein-Barr Virus LMP1 in B Lymphocyte Responses
Abstract
The effect of the Epstein-Barr virus (EBV) latent membrane protein 1 (LMP1) on the activation and differentiation of normal B cells was investigated. B cells of transgenic mice expressing LMP1 under the control of immunoglobulin promoter/enhancer displayed enhanced expression of activation antigens and spontaneously proliferated and produced antibody. Humoral immune responses of LMP1 transgenic mice in CD40-deficient or normal backgrounds revealed that LMP1 mimics CD40 signals to induce extrafollicular B cell differentiation but, unlike CD40, blocks germinal center formation. Thus, these specific properties of LMP1 may determine the site of primary B cell infection and the state of infection in the natural course of EBV infection, whereas subsequent loss of LMP1 expression may affect the site of persistent latent infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation
Hsu, H., Xiong, J., & Goeddel, D. V. (1995) · Cell · doi:10.1016/0092-8674(95)90070-5 · Cited by 2,012
A novel form of Epstein-Barr virus latency in normal B cells in vivo
Miyashita, E. M., Yang, B., Lam, K. M. C., Crawford, D. H., & Thorley-Lawson, D. A. (1995) · Cell · doi:10.1016/0092-8674(95)90513-8 · Cited by 1,593
An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells
Wang, D., Liebowitz, D., & Kieff, E. (1985) · Cell · doi:10.1016/0092-8674(85)90256-9 · Cited by 1,225
Kawabe, T., Naka, T., Yoshida, K., Tanaka, T., Fujiwara, H., Suematsu, S., Yoshida, N., Kishimoto, T., & Kikutani, H. (1994) · Immunity · doi:10.1016/1074-7613(94)90095-7 · Cited by 1,108
Self-citationRothe, M., Wong, S. C., Henzel, W. J., & Goeddel, D. V. (1994) · Cell · doi:10.1016/0092-8674(94)90532-0 · Cited by 1,054
Mosialos, G., Birkenbacht, M., Yalamanchill, R., Van Arsdale, T., Ware, C., & Kleff, E. (1995) · Cell · doi:10.1016/0092-8674(95)90489-1 · Cited by 980
Control of Inflammation, Cytokine Expression, and Germinal Center Formation by BCL-6
Dent, A. L., Shaffer, A. L., Yu, X., Allman, D., & Staudt, L. M. (1997) · Science · doi:10.1126/science.276.5312.589 · Cited by 945
EBV Persistence in Memory B Cells In Vivo
Babcock, G. J., Decker, L. L., Volk, M., & Thorley-Lawson, D. A. (1998) · Immunity · doi:10.1016/s1074-7613(00)80622-6 · Cited by 825
The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation
Ye, B. H., Cattoretti, G., Shen, Q., Zhang, J., Hawe, N., Waard, R. D., Leung, C., Nouri-Shirazi, M., Orazi, A., Chaganti, R. S. K., et al. (1997) · Nature Genetics · doi:10.1038/ng0697-161 · Cited by 820
Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation.
Kaye, K. M., Izumi, K. M., & Kieff, E. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.19.9150 · Cited by 762
Mice deficient for the CD40 ligand
Xu, J., Foy, T. M., Laman, J. D., Elliott, E. A., Dunn, J. J., Waldschmidt, T. J., Elsemore, J., Noelle, R. J., & Flavell, R. A. (1994) · Immunity · doi:10.1016/1074-7613(94)90073-6 · Cited by 734
Fütterer, A., Mink, K., Luz, A., Kosco-Vilbois, M. H., & Pfeffer, K. (1998) · Immunity · doi:10.1016/s1074-7613(00)80588-9 · Cited by 732
Jacob, J., Kassir, R., & Kelsoe, G. (1991) · The Journal of experimental medicine · doi:10.1084/jem.173.5.1165 · Cited by 690
Metlay, J. P., Witmer-Pack, M. D., Agger, R., Crowley, M. T., Lawless, D., & Steinman, R. M. (1990) · The Journal of experimental medicine · doi:10.1084/jem.171.5.1753 · Cited by 555
Humoral immune responses in CD40 ligand-deficient mice.
Renshaw, B. R., Fanslow, W. C., Armitage, R. J., Campbell, K. A., Liggitt, D., Wright, B., Davison, B. L., & Maliszewski, C. R. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.5.1889 · Cited by 536
Long-Term Human B Cell Lines Dependent on Interleukin-4 and antibody to CD40
Banchereau, J., de Paoli, P., Vallé, A., Garcia, E., & Rousset, F. (1991) · Science · doi:10.1126/science.1702555 · Cited by 533
Devergne, O., Hatzivassiliou, E., Izumi, K. M., Kaye, K. M., Kleijnen, M. F., Kieff, E., & Mosialos, G. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.12.7098 · Cited by 491
Ishida, T., Mizushima, S.-I., Azuma, S., Kobayashi, N., Tojo, T., Suzuki, K., Aizawa, S., Watanabe, T., Mosialos, G., Kieff, E., et al. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.46.28745 · Cited by 472
Jacob, J., & Kelsoe, G. (1992) · The Journal of experimental medicine · doi:10.1084/jem.176.3.679 · Cited by 463
Involvement of CRAF1, a relative of TRAF, in CD40 signaling
Cheng, G., Cleary, A. M., Ye, Z.-S., Hong, D. I., Lederman, S., & Baltimore, D. (1995) · Science · doi:10.1126/science.7533327 · Cited by 449
Kulwichit, W., Edwards, R. H., Davenport, E. M., Baskar, J. F., Godfrey, V., & Raab-Traub, N. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.20.11963 · Cited by 414
Self-citationLaherty, C. D., Hu, H. M., Opipari, A. W., Wang, F., & Dixit, V. M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35741-7 · Cited by 409
Izumi, K. M., & Kieff, E. D. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12592 · Cited by 394
Independent modes of transcriptional activation by the p50 and p65 subunits of NF-kappa B.
Fujita, T., Nolan, G. P., Ghosh, S., & Baltimore, D. (1992) · Genes & Development · doi:10.1101/gad.6.5.775 · Cited by 369
Latent membrane protein 1of Epstein-Barr virus interacts with JAK3 and activates STAT proteins
Gires, O. (1999) · The EMBO Journal · doi:10.1093/emboj/18.11.3064 · Cited by 350
A novel RING finger protein interacts with the cytoplasmic domain of CD40.
Hu, H. M., O'Rourke, K., Boguski, M. S., & Dixit, V. M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)43772-6 · Cited by 341
Ishida, T. K., Tojo, T., Aoki, T., Kobayashi, N., Ohishi, T., Watanabe, T., Yamamoto, T., & Inoue, J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9437 · Cited by 336
Affinity maturation without germinal centres in lymphotoxin-α-deficient mice
Matsumoto, M., Lo, S. F., Carruthers, C. J. L., Min, J., Mariathasan, S., Huang, G., Plas, D. R., Martin, S. M., Geha, R. S., Nahm, M. H., et al. (1996) · Nature · doi:10.1038/382462a0 · Cited by 318
Schreiber, E., Matthias, P., Müller, M. M., & Schaffner, W. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb03319.x · Cited by 268
Castigli, E., Alt, F. W., Davidson, L., Bottaro, A., Mizoguchi, E., Bhan, A. K., & Geha, R. S. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.12135 · Cited by 238
Orientation and patching of the latent infection membrane protein encoded by Epstein-Barr virus
Liebowitz, D., Wang, D., & Kieff, E. (1986) · Journal of Virology · doi:10.1128/jvi.58.1.233-237.1986 · Cited by 223
Hammarskjöld, M. L., & Simurda, M. C. (1992) · Journal of Virology · doi:10.1128/jvi.66.11.6496-6501.1992 · Cited by 206
Eliopoulos, A. G., Blake, S. M. S., Floettmann, J. E., Rowe, M., & Young, L. S. (1999) · Journal of Virology · doi:10.1128/jvi.73.2.1023-1035.1999 · Cited by 206
Jak3 Is Associated with CD40 and Is Critical for CD40 Induction of Gene Expression in B Cells
Hanissian, S. H., & Geha, R. S. (1997) · Immunity · doi:10.1016/s1074-7613(00)80281-2 · Cited by 205
Rowe, M., Peng-Pilon, M., Huen, D. S., Hardy, R., Croom-Carter, D., Lundgren, E., & Rickinson, A. B. (1994) · Journal of Virology · doi:10.1128/jvi.68.9.5602-5612.1994 · Cited by 200
Cumano, A., & Rajewsky, K. (1985) · European Journal of Immunology · doi:10.1002/eji.1830150517 · Cited by 192
Patterns of Epstein-Barr virus infection in non-neoplastic lymphoid tissue
Niedobitek, G., Herbst, H., Young, L., Brooks, L., Masucci, M., Crocker, J., Rickinson, A., & Stein, H. (1992) · Blood · doi:10.1182/blood.v79.10.2520.2520 · Cited by 190
Cohen, J. I., Wang, F., & Kieff, E. (1991) · Journal of Virology · doi:10.1128/jvi.65.5.2545-2554.1991 · Cited by 183
Sato, T., Irie, S., & Reed, J. C. (1995) · FEBS Letters · doi:10.1016/0014-5793(94)01406-q · Cited by 175
Characterization of LMP-1's association with TRAF1, TRAF2, and TRAF3
Sandberg, M., Hammerschmidt, W., & Sugden, B. (1997) · Journal of Virology · doi:10.1128/jvi.71.6.4649-4656.1997 · Cited by 166
An Epstein-Barr Virus Transforming Protein Associates with Vimentin in Lymphocytes
Liebowitz, D., Kopan, R., Fuchs, E. V., Sample, J. T., & Kieff, E. D. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.7.2299 · Cited by 122
Jabara, H. H., Schneider, L. C., Shapira, S. K., Alfieri, C., Moody, C. T., Kieff, E. D., Geha, R. S., & Vercelli, D. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.10.3468 · Cited by 79
Liebowitz, D., Mannick, J. B., Takada, K., & Kieff, E. D. (1992) · Journal of Virology · doi:10.1128/jvi.66.7.4612-4616.1992 · Cited by 62
Affinity Maturation in Lyn Kinase-Deficient Mice with Defective Germinal Center Formation
Kato, J., Motoyama, N., Taniuchi, I., TAKESHITA, H., Toyoda, M., Masuda, K., & Watanabe, T. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.10.4788 · Cited by 49
Cited by
Epstein–Barr virus: 40 years on
Young, L. S., & Rickinson, A. B. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1452 · Cited by 2,227
Victora, G. D., & Nussenzweig, M. C. (2012) · Annual Review of Immunology · doi:10.1146/annurev-immunol-020711-075032 · Cited by 1,878
Cohen, J. I. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008173430707 · Cited by 1,636
Hirano, T., Ishihara, K., & Hibi, M. (2000) · Oncogene · doi:10.1038/sj.onc.1203551 · Cited by 1,190
Persistence of the Epstein–Barr Virus and the Origins of Associated Lymphomas
Thorley-Lawson, D. A., & Gross, A. (2004) · New England Journal of Medicine · doi:10.1056/nejmra032015 · Cited by 1,054
Metadata
- Authors
- Uchida, J., Yasui, T., Takaoka-Shichijo, Y., Muraoka, M., Kulwichit, W., Raab-Traub, N., & Kikutani, H.
- Venue
- Science
- Published
- 1999-10-08
- Volume
- 286
- Issue
- 5438
- Pages
- 300-303
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2042610497
- Cited by
- 437
- References
- 44
- FWCI
- 8.75
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.